| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 23.704 | 26.255 | 27.145 | 27.483 | 25.007 | 31.298 | 34.657 | 11.039 | 0 |
| Total Income - EUR | - | 23.704 | 26.255 | 27.145 | 27.484 | 27.008 | 31.474 | 34.771 | 11.039 | 0 |
| Total Expenses - EUR | - | 3.007 | 4.416 | 9.274 | 8.525 | 8.018 | 7.602 | 9.746 | 17.937 | 15.254 |
| Gross Profit/Loss - EUR | - | 20.696 | 21.838 | 17.871 | 18.958 | 18.990 | 23.871 | 25.026 | -6.898 | -15.254 |
| Net Profit/Loss - EUR | - | 19.985 | 21.051 | 17.057 | 18.134 | 18.293 | 23.267 | 24.424 | -7.008 | -15.254 |
| Employees | - | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 0 |
Check the financial reports for the company - Dumamed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 20 | 919 | 602 | 295 | 0 | 0 | 14.037 | 29.655 | 19.659 |
| Current Assets | - | 20.313 | 20.803 | 17.135 | 19.564 | 41.003 | 41.617 | 57.074 | 41.332 | 26.587 |
| Inventories | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | 13.721 | 14.960 | 13.655 | 12.336 | 39.084 | 39.767 | 56.499 | 40.088 | 25.179 |
| Cash | - | 6.592 | 5.843 | 3.480 | 7.228 | 1.919 | 1.849 | 574 | 1.244 | 1.408 |
| Shareholders Funds | - | 20.030 | 21.103 | 17.108 | 18.184 | 18.343 | 23.346 | 47.842 | 40.689 | 25.292 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 304 | 619 | 628 | 1.674 | 22.660 | 18.271 | 23.269 | 30.297 | 20.955 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Dumamed S.r.l.